Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001223808 | SCV001395974 | pathogenic | not provided | 2023-12-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp237*) in the CERKL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CERKL are known to be pathogenic (PMID: 14681825, 23591405, 24043777). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CERKL-related conditions. ClinVar contains an entry for this variant (Variation ID: 951816). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003473781 | SCV004211589 | likely pathogenic | Retinitis pigmentosa 26 | 2023-05-18 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003887920 | SCV004706405 | uncertain significance | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Fulgent Genetics, |
RCV003473781 | SCV005655333 | likely pathogenic | Retinitis pigmentosa 26 | 2024-04-25 | criteria provided, single submitter | clinical testing |